Back to index
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
Life Science Leader
Data Management and Information Technology—Do the Benefits Outweigh the Risks?
Life Science Leader
Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput
Life Science Leader
Not A Popularity Contest
PharmPro
Outsourcing Clinical Research: Established vs. Emerging Markets
April 2012
March 2012
February 2012
January 2012
December 2011
Pharma iQ
Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets
PharmPro
Who should be doing your Pharmaceutical Analytical Testing – a CRO or CMO?
Pharmaceutical Manufacturing
Rating Pharma Contract Manufacturers: Does Perception Equal Reality?
BioSpace
Nice Insight Announces Publication of Its Q4 CRO/CMO Quarterly Intelligence Report
November 2011
October 2011
Life Science Leader
Will A Focus On Innovation Pay Off For Custom Synthesis Providers?
FiercePharma Manufacturing
Top 10 Standout CMOs
BioPharm International
Contract Services Spending: Who's Spending What, and Where?
Pharmaceutical Outsouring
How Relevant are 483s in Terms of Compliance Perception?
SFGate, PRWeb
Therapure Biopharma Inc. wins The CMO Leadership Award
Life Science Leader
Social Media Leads To Editorial – And More
PharmPro
Sterile Manufacturing Oppportunities
Life Science Leader — CMO Leadership Awards supplement issue
It’s About the Customer
PharmaChem
Where do strategic business opportunities lie for mid-tier CROs?
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
NI Company News
NI Published Articles
NI Calendar of Events
NI Media Partners
Contact Us
September 16-18 Long Branch, NJ
 |
|
|
SFGate, PRWeb
October 2011
Contact
Dina Iezzi Director, Marketing and Special Projects +1 905 286 6270      
|
Toronto, Ontario (PRWEB) October 13, 2011 — Therapure Biopharma Inc., announced today that it won the 2011 CMO Leadership Award recognizing Therapure as a category leader for both Regulatory and Productivity. The CMO Leadership Award is based on industry research conducted by Nice Insight and presented by Life Science Leader Magazine. Therapure scored an 81% customer perception (CP) rating in Q3 as published in the October 6, 2011 FiercePharma Manufacturing online article. In accepting the award, Therapure’s President and Chief Executive Officer, Mr. Nick Green said: “We are delighted and honoured to receive this recognition award as Therapure establishes itself as the solution oriented CMO of choice for the biopharma industry. Compliance and productivity are two essential areas of our business, which are fundamental to customers who trust Therapure to meet their biologic manufacturing and aseptic fill/finish needs. We take great pride in being able to offer an integrated service ranging from the production of cell lines to cGMP manufacturing through to final drug product at our cGMP compliant and state-of-the-art facility located 15 minutes from Toronto’s Lester B. Pearson International Airport” Theapure will be recognized as an award winner at the 2011 AAPS Annual Meeting and Exposition in Washington, DC where Therapure representatives will be available at booth #1560 to discuss solutions for your outsource manufacturing needs. About Therapure Biopharma: Therapure Biobiopharma Inc. is an integrated contract development and manufacturing organization (CDMO) that develops and manufactures (upstream and downstream processing) therapeutic proteins as well as provides aseptic fill/finish services for both complex biologics and small molecules. As a CDMO, Therapure applies greater than 20 years of scientific and biologics manufacturing expertise to develop efficient and innovative solutions to advance your products from discovery to market. Throughout the product development process, Therapure has the ability to provide these services in a fully scalable manner. Established development and manufacturing partnerships with a mixture of companies ranging from start-up to large multi-nationals has provided Therapure with a deep understanding of their client’s project specific needs. With our large, flexible, state-of-the-art facility as well as integrated services, Therapure can provide customer-focused manufacturing solutions giving clients the ability to Start with Us and Stay with Us thereby reducing the time and cost of a technology transfer. For more information, please visit: http://www.therapurebio.com Therapure Contacts: Dina Iezzi Director, Marketing and Special Projects (905) 286-6270 diezzi@therapurebio.com |
|
|
 |
|
